Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi By Investing.com
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi…
48,750€
0,93%
Echtzeit-Aktienkurs TG Therapeutics
Bid:
Ask:
Nachrichten zur TG Therapeutics Aktie
TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript
…
G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
…
TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
Conference call to be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET Conference call to be held tomorrow,…
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of…
G1 Therapeutics, Inc. (GTHX) Q4 2023 Earnings Call Transcript
…
TG Therapeutics, Inc. (TGTX) Q4 2023 Earnings Call Transcript
…